4Cell CHO Platform
Protein characterization analysis, cell banking, safety testing services
You can check the following from this catalog: ■ 4Cell CHO Platform: Integrated service package from DNA to cell banking ■ Client management ■ Protein characterization analysis testing services ■ Biosimilar testing ■ GMP cell banking ■ Cell banking services ■ GMP cell bank characterization analysis ■ Package for cell banking & testing services
basic information
The foundation for the approval of new biopharmaceuticals is formed by a robust analytical data package that demonstrates the safety, purity, and efficacy of the product. Sartorius's analytical testing package combines physicochemical analysis methods with biological analysis methods, providing detailed characterization tailored to each customer. Our services enable rapid data-driven decision-making during drug development using platform methods, off-the-shelf assays, and custom-developed bioassays, available from preclinical to clinical stages and lot release.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（13）
Download All Catalogs
News about this product（3）
-
I will send you the viewing URL - Flexible and comprehensive services related to CHO cell line development.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Sartorius has developed CHO cell lines for over 300 projects, with 7 projects approved and more than 80 in clinical trials. The projects include IgG1, 2, 4, multi-specific antibodies, Fc fusion proteins, enzymes, hormones, new drugs, and biosimilars. Our customers range from large companies to startups, with over 70% of them being repeat clients. In this webinar, we will introduce the details of our flexible and comprehensive services, including CHO cell line development, MCB/WCB manufacturing and testing, molecular characterization, FUT8 Knock Out, provision of optimized media, and process enhancement. *We sincerely apologize, but we kindly ask that participants refrain from joining with email addresses other than those from your company or organization. Thank you for your understanding.
-
Announcement of Participation and Seminar Presentation at BioProcess International Asia 2024
This event has ended. We will be exhibiting and presenting at BioProcess International Asia 2024, which will be held in Kyoto from October 21 to 23, 2024. We will introduce Sartorius's cell line development solutions that comprehensively support the commercialization of biopharmaceuticals through products, services, experience, and expertise. 【Event Overview】 Date: October 21 (Monday) 9:00 AM - October 23 (Wednesday) 5:30 PM Location: The Westin Miyako Kyoto *Pre-registration required 【Our Seminar】 Title: Fit for Future: Advancing Bioprocess Manufacturing by Identifying Top Performing Clones and Enhancing Productivity through Process Intensification Seminar Date: October 22 (Tuesday) 9:30 AM
-
I will send you the viewing URL for CHO culture medium development, manufacturing services, and global supply system.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. The media required for pharmaceutical development varies by development phase, making it important to choose a media partner with flexible options and a robust supply system. This webinar will focus on CHO media, introducing services for developing media with optimal compositions for your cell lines, prototype manufacturing services for supplying specified compositions in a short period, and a global manufacturing system that supports commercial production. 【Seminar Overview】 ▪ Date: September 5 (Thursday) from 15:00 (approximately 30 minutes) ▪ Method: Webinar recorded broadcast [Japanese, free] If you are unable to participate on the day, please register first. We will send you the URL for viewing later. *We regret to inform you that participation from other companies in the same industry and email addresses not associated with your organization is not permitted. Thank you for your understanding.
